Diagnostic Utility of N-terminal pro-Brain Natriuretic Peptide and C-reactive Protein in Diagnosing Heart Failure in Patients with Acute Hypoxemic Respiratory Failure.
c-reactive protein
n terminal pro bnp
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
31 Jan 2020
31 Jan 2020
Historique:
entrez:
18
3
2020
pubmed:
18
3
2020
medline:
18
3
2020
Statut:
epublish
Résumé
Introduction Shortness of breath is a leading cause of intensive care unit (ICU) admissions and is multifactorial. Acute hypoxemic respiratory failure due to heart failure is one of the leading causes of ICU admissions. N-terminal pro-brain natriuretic peptide (NT-proBNP) is secreted by ventricles and carries a negative predictive value for heart failure (2). NT-proBNP can also be raised in sepsis (4). Changes in NT-proBNP strongly correlated with changes in C-reactive protein (CRP) and leukocytes levels (8). Objective This study was conducted to explore the diagnostic utility of NT-proBNP and CRP to diagnose heart failure in patients presenting with acute hypoxemic respiratory failure. Materials and methods After informed consent and approval from the institutional review board (IRB), patients of acute hypoxemic respiratory failure were included in the study. History and physical examination were done by a medical resident and recorded in the patients' files. Data were transferred to a structured proforma by the researcher. All tests were conducted within three hours of presentation. The diagnosis of heart failure was made by a panel of experts, including the consultant cardiologist and consultant intensivist in charge. The chest X-ray was reported by the radiologist. The cost of the test was afforded by the institution. Data were analyzed by SPSS version 15 (SPSS Inc., Chicago, Illinois). Analysis of variance (ANOVA), Pearson correlation and linear regression were applied to find out the relation between variables and significance. Results We studied 137 patients. Out of them, 72.9% were diagnosed as heart failure. Heart failure was more common in females (43.7%) as compared to males (29%). NT-proBNP was raised in 111 (81%) patients and out of them, 88 patients (79%) had heart failure. Sensitivity and specificity of NT-proBNP were found to be (95.56%) and (46.81%), respectively. Similarly, CRP was 90% sensitive and 25.53% specific for heart failure. The most common findings in chest X-rays of patients with heart failure were upper lobe diversion and enlarged cardiothoracic ratio (71%). Conclusion We concluded our study as NT-proBNP is a highly sensitive test to diagnose heart failure in settings of acute hypoxemic respiratory failure. CRP is also significantly raised in heart failure. Upper lobe diversion and an increased cardiothoracic ratio is a strong predictor of heart failure.
Identifiants
pubmed: 32181077
doi: 10.7759/cureus.6835
pmc: PMC7051103
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e6835Informations de copyright
Copyright © 2020, Abdullah et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Emerg Med. 2012 Feb;42(2):197-205
pubmed: 22123173
Am J Emerg Med. 2005 Jul;23(4):501-3
pubmed: 16032620
J Thorac Dis. 2013 Sep;5 Suppl 4:S397-406
pubmed: 24102013
Pediatrics. 2006 Oct;118(4):e1165-8
pubmed: 16966393
Crit Care. 2010;14(4):184
pubmed: 20712913
Crit Care Med. 2008 Nov;36(11):3030-7
pubmed: 18824903
Health Technol Assess. 2009 Jul;13(32):1-207, iii
pubmed: 19586584
Crit Care. 2004 Aug;8(4):R248-50
pubmed: 15312225
Am J Emerg Med. 2018 Dec;36(12):2236-2241
pubmed: 29655502
Heart. 2005 May;91(5):606-12
pubmed: 15831643
Int J Cardiol. 2008 May 7;126(1):28-31
pubmed: 17477984
J Pharmacol Exp Ther. 1999 May;289(2):976-80
pubmed: 10215677
J Crit Care. 2018 Dec;48:145-152
pubmed: 30195194
Clin Chem. 2007 Jul;53(7):1264-72
pubmed: 17478561
Crit Care Med. 2006 Aug;34(8):2140-4
pubmed: 16763507
Crit Care. 2014 Jul 01;18(4):161
pubmed: 25042534
Clin J Am Soc Nephrol. 2008 Nov;3(6):1644-51
pubmed: 18632852
Crit Care Med. 2004 Aug;32(8):1643-7
pubmed: 15286538